Nautilus Biotechnology, Inc.
General ticker "NAUT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $217.6M (TTM average)
Nautilus Biotechnology, Inc. follows the US Stock Market performance with the rate: 5.3%.
Estimated limits based on current volatility of 4.1%: low 0.91$, high 0.98$
Factors to consider:
- Total employees count: 130 (-16.1%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Net losses, Operational and conduct risks, Platform failures, Capital raising, IP protection failure
- Current price 26.5% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.31$, 3.21$]
- 2026-12-31 to 2027-12-31 estimated range: [1.19$, 2.87$]
Financial Metrics affecting the NAUT estimates:
- Positive: with PPE of -4.2 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -20.50 <= 0.28
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 14.24 > -0.64
- Negative: Shareholder equity ratio, % of 82.14 > 63.63
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term NAUT quotes
Long-term NAUT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $76.15MM | $81.48MM | $66.84MM |
| Operating Income | $-76.15MM | $-81.48MM | $-66.84MM |
| Non-Operating Income | $12.48MM | $10.70MM | $7.84MM |
| R&D Expense | $47.25MM | $50.48MM | $41.11MM |
| Income(Loss) | $-63.67MM | $-70.78MM | $-59.00MM |
| Net Income(Loss)* | $-63.67MM | $-70.78MM | $-59.00MM |
| Stockholders Equity | $265.35MM | $208.73MM | $156.97MM |
| Assets | $305.56MM | $242.74MM | $191.11MM |
| Operating Cash Flow | $-51.71MM | $-59.15MM | $-50.70MM |
| Capital expenditure | $2.44MM | $2.12MM | $1.28MM |
| Investing Cash Flow | $-43.73MM | $66.25MM | $35.22MM |
| Financing Cash Flow | $0.37MM | $1.14MM | $0.21MM |
| Earnings Per Share** | $-0.51 | $-0.56 | $-0.47 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.